First-milestone-funding: Development of heart-specific adeno-associated viruses (AAVs) prototypes via genetic capsid engineering for intravenous cardiac gene delivery
| Institution | Universitätsklinikum Heidelberg |
|---|---|
| Project leader | Patrick Most |
| Site | Heidelberg/Mannheim |
| Project type | Innovation Cluster |
| Funding | € 90.186,00 |
| Begin | 01.10.2018 |
| End | 30.11.2019 |
| Partnerprojekte |
|
Förderkennzeichen
81X2500174
Projektnummer
1008